Companies: 10,795·Total market cap: $144.5T
Knight Therapeutics Inc.

Knight Therapeutics Inc.

GUD.TOTSXHealthcare● Active
$8.61
+$0.15(+1.77%)
Market Cap$844078767
P/E Ratio—
52W High$8.9
52W Low$5.66
ForecastMarket CapPE Ratio

Knight Therapeutics Inc.（GUD.TO）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

gud.to · 股价预测 · 1 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 1 位华尔街分析师

SellBuy

Buy

1 位分析师

共识

评级分布

Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
合计: 1 · 买入占比: 100.0%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $8.61

Knight Therapeutics Inc.（GUD.TO）的分析师共识为 Buy，基于过去 3 个月内 1 位华尔街分析师的评级。GUD.TO 的 12 个月平均目标价为 $0.00，相对当前价 $8.61 代表 +0.0% 的潜在上行空间。

短期股价预测

Bull

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$8.61↓ 0.01%

1-day model range: $8.57–$8.65. Peak: $8.65 (-0.01%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$10+19.7%
2028$11+32.7%
2029$12+40.7%
2030$13+45.3%
2031—+47.9%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

93%7%0%
13Buy
1Neutral
0Sell
RSI (14)55.7Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · GUD.TO · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$8.36BUY
MA 10$8.25BUY
MA 20$8.36BUY
MA 50$7.86BUY
MA 100$7.00BUY
MA 200$6.53BUY
Current $GUD.TO · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$8.41BUY
EMA 10$8.32BUY
EMA 20$8.22BUY
EMA 50$7.81BUY
EMA 100$7.29BUY
EMA 200$6.78BUY
Current $GUD.TO · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Raymond James2024-03-06
Maintains
Outperform→Outperform

Wall Street analysts have recently issued updated ratings on Knight Therapeutics Inc. (GUD.TO) stock. Of the recent 1 rating actions, 0 were upgrades and 0 were downgrades. 1 analysts currently cover GUD.TO.

分析师推荐趋势

Buy ratings1 → 1
Hold ratings0 → 0
Sell ratings0 → 0

GUD.TO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$520M

↓ 5.0% YoY

Revenue Next Year

$528M

↑ 1.4% YoY

EPS This Year

$0.18

EPS Next Year

$0.21

↑ 14.1% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast GUD.TO EPS of $0.18 for the current fiscal year, based on estimates from 3 analysts. The GUD.TO revenue forecast is $520M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

GUD.TO 股价预测由两类独立数据源支撑：来自 1 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。GUD.TO 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。

GUD.TO 的短期预测（明日）为 $8.61（-0.01%）。 GUD.TO 对 2027 年的股价预测均值为 $10。 GUD.TO 对 2030 年的预测区间为 $12–$13。

Knight Therapeutics Inc. 在 TSX 上市，代码 GUD.TO。GUD.TO 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

相关页面

盈利营收市盈率财务报表市值内幕交易股息价格历史

常见问题

GUD.TO 预测 · 8 个问题

根据 1 位华尔街分析师，GUD.TO 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $8.61，隐含约 +0.0% 的上行空间。

GUD.TO 目标价GUD.TO 分析师目标价GUD.TO 12个月目标价目标价 GUD.TO

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.